Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients With Acromegaly

PLoS ONE - United States
doi 10.1371/journal.pone.0110241
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Prognostic Utility of BRAF Mutation in Papillary Thyroid Cancer

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2010English

Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival

Annals of Surgery
Surgery
2014English

Redifferentiation of Iodine-Refractory BRAF V600e-Mutant Metastatic Papillary Thyroid Cancer With Dabrafenib

Clinical Cancer Research
Cancer ResearchOncology
2014English

Surgical Tactics Optimization for Treatment of BRAF Positive Papillary Thyroid Cancer

Clinical and experimental thyroidology
2018English

The BRAF V600E Mutation Is a Predictor of the Effect of Radioiodine Therapy in Papillary Thyroid Cancer

Journal of Cancer
Oncology
2020English

BRAF-V600E Is Not Involved in the Colorectal Tumorigenesis of HNPCC in Patients With Functional MLH1 and MSH2 Genes

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Thyroid Cancer Risk Is Not Increased in Diabetic Patients

PLoS ONE
Multidisciplinary
2012English

Recent Outcome of Graves' Disease Patients With Papillary Thyroid Cancer

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2007English

Is Radioiodine Administration in Patients With Papillary Thyroid Multifocal Microcarcinoma Unnecessary?

Endocrinology, Diabetes and Metabolism Case Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy